nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—Breast mass—Octreotide—thymus cancer	0.0995	0.113	CcSEcCtD
Etonogestrel—Breast pain female—Octreotide—thymus cancer	0.0791	0.0898	CcSEcCtD
Etonogestrel—Varicose vein—Octreotide—thymus cancer	0.0308	0.035	CcSEcCtD
Etonogestrel—Local reaction—Octreotide—thymus cancer	0.0207	0.0235	CcSEcCtD
Etonogestrel—Pregnancy—Octreotide—thymus cancer	0.0202	0.0229	CcSEcCtD
Etonogestrel—Haematoma—Octreotide—thymus cancer	0.0183	0.0207	CcSEcCtD
Etonogestrel—Galactorrhoea—Octreotide—thymus cancer	0.0177	0.0201	CcSEcCtD
Etonogestrel—Redness—Octreotide—thymus cancer	0.017	0.0193	CcSEcCtD
Etonogestrel—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.0168	0.0191	CcSEcCtD
Etonogestrel—Metrorrhagia—Octreotide—thymus cancer	0.0161	0.0182	CcSEcCtD
Etonogestrel—Influenza-like symptoms—Octreotide—thymus cancer	0.0161	0.0182	CcSEcCtD
Etonogestrel—Otitis media—Octreotide—thymus cancer	0.0147	0.0167	CcSEcCtD
Etonogestrel—Injection site pain—Octreotide—thymus cancer	0.0141	0.016	CcSEcCtD
Etonogestrel—Acne—Octreotide—thymus cancer	0.0136	0.0155	CcSEcCtD
Etonogestrel—Contusion—Octreotide—thymus cancer	0.0131	0.0149	CcSEcCtD
Etonogestrel—Breast pain—Octreotide—thymus cancer	0.0131	0.0149	CcSEcCtD
Etonogestrel—Amenorrhoea—Octreotide—thymus cancer	0.0131	0.0148	CcSEcCtD
Etonogestrel—Herpes simplex—Octreotide—thymus cancer	0.0124	0.0141	CcSEcCtD
Etonogestrel—SHBG—neck—thymus cancer	0.0117	0.0981	CbGeAlD
Etonogestrel—Vaginal inflammation—Octreotide—thymus cancer	0.0115	0.013	CcSEcCtD
Etonogestrel—Injection site reaction—Octreotide—thymus cancer	0.0114	0.0129	CcSEcCtD
Etonogestrel—Cystitis noninfective—Octreotide—thymus cancer	0.0112	0.0127	CcSEcCtD
Etonogestrel—Influenza like illness—Octreotide—thymus cancer	0.0111	0.0126	CcSEcCtD
Etonogestrel—Cystitis—Octreotide—thymus cancer	0.0111	0.0126	CcSEcCtD
Etonogestrel—Vaginal infection—Octreotide—thymus cancer	0.0108	0.0123	CcSEcCtD
Etonogestrel—Bladder pain—Octreotide—thymus cancer	0.0104	0.0118	CcSEcCtD
Etonogestrel—Hot flush—Octreotide—thymus cancer	0.0089	0.0101	CcSEcCtD
Etonogestrel—Menopausal symptoms—Octreotide—thymus cancer	0.00883	0.01	CcSEcCtD
Etonogestrel—Visual disturbance—Octreotide—thymus cancer	0.00879	0.00998	CcSEcCtD
Etonogestrel—SHBG—hematopoietic system—thymus cancer	0.00869	0.073	CbGeAlD
Etonogestrel—Pain in extremity—Octreotide—thymus cancer	0.00833	0.00945	CcSEcCtD
Etonogestrel—ESR1—neck—thymus cancer	0.00823	0.0691	CbGeAlD
Etonogestrel—Irritability—Octreotide—thymus cancer	0.00795	0.00902	CcSEcCtD
Etonogestrel—PGR—hematopoietic system—thymus cancer	0.00783	0.0658	CbGeAlD
Etonogestrel—Cramp muscle—Octreotide—thymus cancer	0.0075	0.00851	CcSEcCtD
Etonogestrel—Gastritis—Octreotide—thymus cancer	0.00737	0.00837	CcSEcCtD
Etonogestrel—Abdominal distension—Octreotide—thymus cancer	0.00725	0.00822	CcSEcCtD
Etonogestrel—Asthma—Octreotide—thymus cancer	0.0072	0.00817	CcSEcCtD
Etonogestrel—PGR—epithelium—thymus cancer	0.00716	0.0601	CbGeAlD
Etonogestrel—Bronchitis—Octreotide—thymus cancer	0.00692	0.00786	CcSEcCtD
Etonogestrel—Dysuria—Octreotide—thymus cancer	0.00673	0.00764	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Octreotide—thymus cancer	0.00669	0.00759	CcSEcCtD
Etonogestrel—Pollakiuria—Octreotide—thymus cancer	0.00665	0.00755	CcSEcCtD
Etonogestrel—Weight increased—Octreotide—thymus cancer	0.00655	0.00744	CcSEcCtD
Etonogestrel—Weight decreased—Octreotide—thymus cancer	0.00651	0.00739	CcSEcCtD
Etonogestrel—SHBG—pituitary gland—thymus cancer	0.00645	0.0542	CbGeAlD
Etonogestrel—Depression—Octreotide—thymus cancer	0.0064	0.00726	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Octreotide—thymus cancer	0.00629	0.00714	CcSEcCtD
Etonogestrel—Urinary tract infection—Octreotide—thymus cancer	0.00624	0.00708	CcSEcCtD
Etonogestrel—ESR1—hematopoietic system—thymus cancer	0.00612	0.0515	CbGeAlD
Etonogestrel—Sinusitis—Octreotide—thymus cancer	0.00602	0.00683	CcSEcCtD
Etonogestrel—PGR—pituitary gland—thymus cancer	0.00581	0.0488	CbGeAlD
Etonogestrel—Rhinitis—Octreotide—thymus cancer	0.00578	0.00656	CcSEcCtD
Etonogestrel—Hypoaesthesia—Octreotide—thymus cancer	0.00573	0.00651	CcSEcCtD
Etonogestrel—Pharyngitis—Octreotide—thymus cancer	0.00572	0.00649	CcSEcCtD
Etonogestrel—ESR1—epithelium—thymus cancer	0.0056	0.047	CbGeAlD
Etonogestrel—SHBG—bone marrow—thymus cancer	0.00557	0.0468	CbGeAlD
Etonogestrel—SHBG—thyroid gland—thymus cancer	0.00556	0.0467	CbGeAlD
Etonogestrel—Visual impairment—Octreotide—thymus cancer	0.00555	0.0063	CcSEcCtD
Etonogestrel—PGR—lymphoid tissue—thymus cancer	0.00551	0.0463	CbGeAlD
Etonogestrel—Immune system disorder—Octreotide—thymus cancer	0.0052	0.00591	CcSEcCtD
Etonogestrel—Alopecia—Octreotide—thymus cancer	0.00509	0.00578	CcSEcCtD
Etonogestrel—Mental disorder—Octreotide—thymus cancer	0.00505	0.00573	CcSEcCtD
Etonogestrel—Erythema—Octreotide—thymus cancer	0.00502	0.00569	CcSEcCtD
Etonogestrel—Malnutrition—Octreotide—thymus cancer	0.00502	0.00569	CcSEcCtD
Etonogestrel—PGR—thyroid gland—thymus cancer	0.00501	0.0421	CbGeAlD
Etonogestrel—Flatulence—Octreotide—thymus cancer	0.00494	0.00561	CcSEcCtD
Etonogestrel—Tension—Octreotide—thymus cancer	0.00492	0.00559	CcSEcCtD
Etonogestrel—Nervousness—Octreotide—thymus cancer	0.00487	0.00553	CcSEcCtD
Etonogestrel—Back pain—Octreotide—thymus cancer	0.00485	0.00551	CcSEcCtD
Etonogestrel—Muscle spasms—Octreotide—thymus cancer	0.00482	0.00547	CcSEcCtD
Etonogestrel—Ill-defined disorder—Octreotide—thymus cancer	0.00465	0.00528	CcSEcCtD
Etonogestrel—PGR—lung—thymus cancer	0.00455	0.0382	CbGeAlD
Etonogestrel—ESR1—pituitary gland—thymus cancer	0.00454	0.0382	CbGeAlD
Etonogestrel—Malaise—Octreotide—thymus cancer	0.00452	0.00513	CcSEcCtD
Etonogestrel—Cough—Octreotide—thymus cancer	0.00438	0.00497	CcSEcCtD
Etonogestrel—Convulsion—Octreotide—thymus cancer	0.00435	0.00493	CcSEcCtD
Etonogestrel—Hypertension—Octreotide—thymus cancer	0.00433	0.00491	CcSEcCtD
Etonogestrel—ESR1—lymphoid tissue—thymus cancer	0.00431	0.0362	CbGeAlD
Etonogestrel—Arthralgia—Octreotide—thymus cancer	0.00427	0.00485	CcSEcCtD
Etonogestrel—Myalgia—Octreotide—thymus cancer	0.00427	0.00485	CcSEcCtD
Etonogestrel—Anxiety—Octreotide—thymus cancer	0.00425	0.00483	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00424	0.00481	CcSEcCtD
Etonogestrel—Discomfort—Octreotide—thymus cancer	0.00422	0.00479	CcSEcCtD
Etonogestrel—Anaphylactic shock—Octreotide—thymus cancer	0.00409	0.00465	CcSEcCtD
Etonogestrel—Oedema—Octreotide—thymus cancer	0.00409	0.00465	CcSEcCtD
Etonogestrel—Infection—Octreotide—thymus cancer	0.00407	0.00462	CcSEcCtD
Etonogestrel—Nervous system disorder—Octreotide—thymus cancer	0.00401	0.00456	CcSEcCtD
Etonogestrel—Skin disorder—Octreotide—thymus cancer	0.00398	0.00451	CcSEcCtD
Etonogestrel—ESR1—thyroid gland—thymus cancer	0.00392	0.0329	CbGeAlD
Etonogestrel—Anorexia—Octreotide—thymus cancer	0.0039	0.00443	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00373	0.00423	CcSEcCtD
Etonogestrel—Insomnia—Octreotide—thymus cancer	0.0037	0.0042	CcSEcCtD
Etonogestrel—Paraesthesia—Octreotide—thymus cancer	0.00368	0.00417	CcSEcCtD
Etonogestrel—Somnolence—Octreotide—thymus cancer	0.00364	0.00413	CcSEcCtD
Etonogestrel—Dyspepsia—Octreotide—thymus cancer	0.0036	0.00409	CcSEcCtD
Etonogestrel—Decreased appetite—Octreotide—thymus cancer	0.00356	0.00404	CcSEcCtD
Etonogestrel—ESR1—lung—thymus cancer	0.00356	0.0299	CbGeAlD
Etonogestrel—Gastrointestinal disorder—Octreotide—thymus cancer	0.00353	0.00401	CcSEcCtD
Etonogestrel—Fatigue—Octreotide—thymus cancer	0.00353	0.00401	CcSEcCtD
Etonogestrel—Pain—Octreotide—thymus cancer	0.0035	0.00397	CcSEcCtD
Etonogestrel—Constipation—Octreotide—thymus cancer	0.0035	0.00397	CcSEcCtD
Etonogestrel—CYP3A4—hematopoietic system—thymus cancer	0.00342	0.0287	CbGeAlD
Etonogestrel—Feeling abnormal—Octreotide—thymus cancer	0.00337	0.00383	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Octreotide—thymus cancer	0.00335	0.0038	CcSEcCtD
Etonogestrel—Urticaria—Octreotide—thymus cancer	0.00325	0.00369	CcSEcCtD
Etonogestrel—Body temperature increased—Octreotide—thymus cancer	0.00324	0.00367	CcSEcCtD
Etonogestrel—Abdominal pain—Octreotide—thymus cancer	0.00324	0.00367	CcSEcCtD
Etonogestrel—PGR—lymph node—thymus cancer	0.00311	0.0261	CbGeAlD
Etonogestrel—Hypersensitivity—Octreotide—thymus cancer	0.00302	0.00342	CcSEcCtD
Etonogestrel—Asthenia—Octreotide—thymus cancer	0.00294	0.00333	CcSEcCtD
Etonogestrel—Pruritus—Octreotide—thymus cancer	0.0029	0.00329	CcSEcCtD
Etonogestrel—Diarrhoea—Octreotide—thymus cancer	0.0028	0.00318	CcSEcCtD
Etonogestrel—Dizziness—Octreotide—thymus cancer	0.00271	0.00307	CcSEcCtD
Etonogestrel—Vomiting—Octreotide—thymus cancer	0.0026	0.00295	CcSEcCtD
Etonogestrel—Rash—Octreotide—thymus cancer	0.00258	0.00293	CcSEcCtD
Etonogestrel—Dermatitis—Octreotide—thymus cancer	0.00258	0.00293	CcSEcCtD
Etonogestrel—Headache—Octreotide—thymus cancer	0.00256	0.00291	CcSEcCtD
Etonogestrel—ESR1—lymph node—thymus cancer	0.00243	0.0204	CbGeAlD
Etonogestrel—Nausea—Octreotide—thymus cancer	0.00243	0.00276	CcSEcCtD
